Idexx Laboratories
IDXX
664 hedge funds and large institutions have $17.5B invested in Idexx Laboratories in 2018 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 213 increasing their positions, 257 reducing their positions, and 48 closing their positions.
46% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 48
28% more funds holding in top 10
Funds holding in top 10: 18 → 23 (+5)
20% more capital invested
Capital invested by funds: $14.6B → $17.5B (+$2.86B)
4.69% more ownership
Funds ownership: 87.63% → 92.32% (+4.7%)
3% more funds holding
Funds holding: 645 → 664 (+19)
8% more call options, than puts
Call options by funds: $46.6M | Put options by funds: $43.2M
17% less repeat investments, than reductions
Existing positions increased: 213 | Existing positions reduced: 257
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$118M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$82.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$45.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$43.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$32.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$90M |
| 2 |
Select Equity Group
New York
|
-$82.1M |
| 3 |
BlackRock
New York
|
-$67.9M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$64.3M |
| 5 |
CCI
Columbus Circle Investors
|
-$35.6M |
IDXX Hedge Fund Activity: Q2 2018 in Review
664 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2018, worth a combined $17.5B — up 20% from $14.6B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new IDXX positions and 48 closed out — a net gain of 22 holders — while 213 added to existing stakes and 257 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $118M. The largest seller was Marshall Wace North America, cutting an estimated $90M.
- 664 institutional investors held Idexx Laboratories (IDXX) as of Q2 2018, up from 645 in Q1 2018.
- Funds reported $17.5B of Idexx Laboratories stock for Q2 2018, up 20% quarter-over-quarter.
- 70 funds opened new Idexx Laboratories positions in Q2 2018 and 48 closed out, a net change of +22 holders.
- The largest Idexx Laboratories buyer in Q2 2018 was Goldman Sachs, an estimated $118M added.
- The largest Idexx Laboratories seller in Q2 2018 was Marshall Wace North America, an estimated $90M sold.
Based on aggregated 13F filings for Q2 2018.